Six years duration of adjuvant imatinib improves disease-free survival in GIST with a high risk of relapse

J. Y. Blay, N. Penel, C. Schiffler, S. Chabaud, D. Perol, A. Le Cesne

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

Accès au document

@article{16a78b5c1d934cb888d9638cb029084a,

title = "Six years duration of adjuvant imatinib improves disease-free survival in GIST with a high risk of relapse",

author = "Blay, {J. Y.} and N. Penel and C. Schiffler and S. Chabaud and D. Perol and {Le Cesne}, A.",

year = "2024",

month = jan,

day = "1",

doi = "10.1016/j.annonc.2024.09.018",

language = "English",

journal = "Annals of Oncology",

issn = "0923-7534",

}

TY - JOUR

T1 - Six years duration of adjuvant imatinib improves disease-free survival in GIST with a high risk of relapse

AU - Blay, J. Y.

AU - Penel, N.

AU - Schiffler, C.

AU - Chabaud, S.

AU - Perol, D.

AU - Le Cesne, A.

PY - 2024/1/1

Y1 - 2024/1/1

UR - http://www.scopus.com/inward/record.url?scp=85208589704&partnerID=8YFLogxK

U2 - 10.1016/j.annonc.2024.09.018

DO - 10.1016/j.annonc.2024.09.018

M3 - Letter

C2 - 39443188

AN - SCOPUS:85208589704

SN - 0923-7534

JO - Annals of Oncology

JF - Annals of Oncology

ER -